IP Library Granted Patent US 10,961,553
Granted Patent B2
US 10,961,553 · App. 15/888,222 · Granted Mar 30, 2021

Methods and compositions for producing fatty alcohols

Inventors: Zhihao Hu (South San Francisco, CA); Vikranth Arlagadda (South San Francisco, CA)
Assignee: Genomatica, Inc.
C12P7/64B21D51/2692C12N1/20C12P7/04A61K31/045C12N9/0004C12N2501/71C12N2502/99C12R1/01Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,553
App. No.
15/888,222
Granted
Mar 30, 2021
Kind
B2
Abstract

Methods and compositions, including nucleotide sequences, amino acid sequences, and host cells, for producing fatty alcohols are described.

Claims (17)

1. A method of producing a fatty alcohol composition, the method comprising expressing in an E. coli cell a gene encoding a polypeptide comprising an amino acid sequence having at least 80% sequence identity to the amino acid sequence selected from group consisting of SEQ ID NO: 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 264, 266, 268, 270, and 272 wherein said polypeptide has carboxylic acid reductases activity, and a gene encoding a polypeptide having alcohol dehydrogenase (EC 1.1.1.*) activity, wherein the alcohol dehydrogenase polypeptide is overexpressed and converts a fatty aldehyde to a fatty alcohol to provide an E. coli cell culture comprising the fatty alcohol composition.

2. The method of claim 1 , wherein the E. coli cell expresses an attenuated level of at least one fatty acid degradation enzyme relative to a wild type E. coli cell.

3. The method of claim 2 , wherein the at least one fatty acid degradation enzyme has acyl-CoA synthase activity.

4. The method of claim 1 , wherein the fatty alcohol composition comprises a C12 fatty alcohol, C14:1 fatty alcohol, C14:0 fatty alcohol, C16:0 fatty alcohol, and C16:1 fatty alcohol.

5. The method of claim 4 , wherein the C12 fatty alcohol, C14:1 fatty alcohol, C14:0 fatty alcohol, C16:0 fatty alcohol, and C16:1 fatty alcohol are each a primary alcohol.

6. The method of claim 1 , wherein the fatty alcohol composition has a C12 to C14 ratio of 3 to 1.

7. The method of claim 1 , wherein the fatty alcohol composition comprises an unsaturated fatty alcohol.

8. The method of claim 7 , wherein the unsaturated fatty alcohol is C10:1, C12:1, C14:1, C16:1, or C18:1.

9. The method of claim 8 , wherein the fatty alcohol is unsaturated at the omega-7 position.

10. The method of claim 7 , wherein the unsaturated fatty alcohol comprises a cis double bond.

11. The method of claim 1 , wherein the fatty alcohol composition comprises a saturated fatty alcohol.

12. The method of claim 11 , wherein the fatty alcohol is a C12 or C14 fatty alcohol.

13. The method of claim 1 , wherein said fatty alcohol is produced by a malonyl-CoA-independent pathway.

14. The method of claim 1 , further comprising isolating the fatty alcohol composition from the E. coli cell culture.

15. The method of claim 1 , wherein the host cell comprises polynucleotide sequences encoding a polypeptide having thioesterase (EC 3.1.2.14 or EC 3.1.1.5) activity effective to release a fatty acid from acyl-ACP.

16. The method of claim 14 , wherein the fatty alcohol composition comprises C12 and C14 fatty alcohols that are primary alcohols.

17. The method of claim 16 , wherein the fatty alcohol composition comprises an unsaturated fatty alcohol.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
Continuity (5)
Continuation 14720240 · May 22, 2015
Continuation 13647185 · Oct 8, 2012
Continuation 12575430 · Oct 7, 2009
Provisional Application 61109131 · Oct 28, 2008
Related Publication 20190017081A1 · Jan 17, 2019